Does Fasting Raise Blood Pressure?

The short answer on fasting and blood pressure

For most people, short-term fasting lowers blood pressure — particularly those with hypertension and insulin resistance. The primary mechanism is the fall in insulin: as insulin drops during a fast, the kidneys excrete more sodium, blood volume decreases, and blood pressure follows. This insulin-mediated natriuretic effect is the dominant direction of change across most clinical studies.

The exception is the first 12 to 24 hours. In that early window, the body shifts toward greater sympathetic nervous system activity as it adapts to reduced glucose availability. Catecholamines rise, blood vessels constrict, and blood pressure can tick upward transiently before the longer-term lowering direction takes over. This is why some people record mildly elevated readings on day one of a fast and assume fasting raises their blood pressure — it can, briefly, before it doesn't.

The relationship is also shaped by baseline metabolic health. People with elevated starting blood pressure and significant insulin resistance tend to see the largest reductions. Those who are already normotensive see smaller, less consistent changes. Fasting protocols also vary widely — from 16-hour daily windows to multi-day extended fasts — and each carries a distinct physiological profile. The blood pressure effects differ accordingly, which is why a single raise-or-lower answer misses most of what matters.

How fasting reshapes blood pressure physiology

The primary lowering mechanism is insulin-mediated natriuresis. During a fast, dietary sodium intake drops to zero and insulin levels fall as blood glucose declines. At lower concentrations, insulin reduces renal sodium reabsorption, which decreases blood volume and lowers blood pressure. This effect is most pronounced in insulin-resistant individuals, whose kidneys have been retaining excess sodium under chronically elevated insulin — the drop during fasting produces a correspondingly larger excretion response. A 2022 review in Nutrients highlights that fasting produces hormonal shifts extending beyond simple caloric restriction, affecting insulin sensitivity and metabolic regulation with downstream effects on blood pressure through this same renal pathway. A secondary lowering mechanism is suppression of the renin-angiotensin-aldosterone system (RAAS), a hormonal cascade that regulates blood pressure through kidney-mediated sodium and water retention. Fasting reduces RAAS activity in some studies, which further decreases the drive for sodium retention — particularly relevant in obesity-related hypertension where RAAS overactivation is common.

Two mechanisms push in the opposite direction. In the early phase of a fast — typically the first 12 to 24 hours — the body elevates catecholamine (adrenaline and noradrenaline) levels as part of its metabolic adaptation to reduced glucose availability. Catecholamines are vasoconstrictors: they narrow blood vessels and increase heart rate, producing a transient blood pressure rise before the sympathetic response attenuates as fat oxidation becomes the primary fuel. Separately, inadequate fluid intake during fasting can cause dehydration, which reduces blood volume and initially activates compensatory mechanisms — increased RAAS activity, sympathetic tone — that raise blood pressure. More severe dehydration eventually overwhelms these compensatory mechanisms and blood pressure drops, often manifesting as orthostatic hypotension when standing. Both directions are explored further in the counterintuitive section below. This fed-versus-fasted dynamic is also the mirror image of what happens after eating — the mechanisms run in reverse, as covered in the companion article on blood pressure after eating.

Over a longer time horizon, if intermittent fasting produces a sustained caloric deficit and results in weight loss, visceral fat reduction adds a third lowering pathway. Visceral adipose tissue is metabolically active: it releases inflammatory mediators, activates RAAS, and contributes to insulin resistance, all of which raise blood pressure. Reduction in visceral adiposity through sustained fasting consistently reduces blood pressure in overweight individuals, compounding the acute insulin-mediated effect over weeks and months.

How much fasting actually moves the number

Multiple clinical studies and meta-analyses indicate that sustained intermittent fasting is associated with systolic blood pressure reductions of 5 to 10 mmHg over several weeks of consistent practice, with corresponding diastolic reductions that are generally smaller in magnitude. A meta-analysis of intermittent fasting and blood pressure confirms modest but meaningful reductions in both systolic and diastolic readings, particularly in people with elevated baseline readings and insulin resistance. The effect is most pronounced in those with higher starting blood pressure; results in normotensive individuals are smaller and less consistent.

Part of the effect in longer-term studies is attributable to weight loss rather than fasting per se. Visceral fat reduction — which fasting can produce through sustained caloric deficit — independently lowers blood pressure through reduced RAAS activation, decreased inflammatory mediator release, and improved insulin sensitivity. In studies where fasting produces meaningful weight loss, the blood pressure reduction tends to be larger and more durable than in studies where body weight is held constant.

These are population-level averages. A 5 to 10 mmHg reduction is clinically meaningful — it corresponds to a measurable reduction in cardiovascular event risk — but it is not universal, and the individual response varies considerably. Who responds and by how much is what the next section addresses.

Why your fasting response won't match the average

The direction and magnitude of blood pressure change with fasting depends on several individual factors. Baseline blood pressure is the strongest predictor: people with higher resting readings show the largest decreases, while those already in the normal range show smaller, less consistent changes. Beyond starting point, the following biomarkers and factors shape the individual response:

• Fasting insulin: The more insulin-resistant an individual, the greater the blood-pressure-lowering effect when insulin falls during a fast — people with insulin resistance show the largest sodium-excretion response because their kidneys have been retaining the most sodium under chronically elevated insulin levels.
• Fasting glucose + HbA1c: Blood sugar regulation provides context for insulin resistance severity and the metabolic substrate for the BP response. Chronically elevated glucose and HbA1c signal the degree of underlying metabolic dysfunction that fasting is working against or with.
• eGFR / kidney function: Impaired sodium handling in reduced kidney function modifies how much blood pressure responds to the insulin-driven natriuresis during fasting. Alongside eGFR, creatinine provides a companion measure of kidney filtration capacity that contextualizes the renal component of the fasting response.
• Triglycerides: Elevated triglycerides reflect metabolic syndrome; the full atherogenic phenotype predicts more meaningful BP response to fasting-induced metabolic improvement, as the underlying drivers of elevated blood pressure are more numerous and more addressable.
• hs-CRP: Systemic vascular inflammation associated with endothelial dysfunction influences how completely blood pressure normalizes as metabolic state improves with fasting. Higher baseline inflammation may blunt or delay the BP response.
• Fasting duration: Short intermittent fasting windows (16 hours) tend to produce modest blood pressure reduction through the insulin mechanism. Extended multi-day fasts may produce more variable responses, including dehydration effects that complicate the picture.
• Medications: Antihypertensive drugs interact directly with fasting's BP-lowering effect — see the next section for the clinical implications.

The fed-state counterpart to this picture is also informative: understanding how your blood pressure responds to eating — covered in the companion article on blood pressure after eating — helps establish the full dynamic range of your individual BP regulation.

Fasting readings that signal something worth checking

The most clinically significant interaction to monitor is between fasting and antihypertensive medications. People who take antihypertensive medications and initiate an intermittent fasting practice may find that their blood pressure falls below its medicated target, particularly if fasting itself has a blood-pressure-lowering effect. This can result in symptomatic hypotension, dizziness, or orthostatic symptoms. Anyone on antihypertensive medications who intends to fast regularly should inform their prescribing provider, as medication adjustment may be warranted during periods of sustained fasting.

Beyond medication interactions, two patterns during fasting warrant attention. First, a transient blood pressure rise in the early fast accompanied by headache or palpitations — while often reflecting normal sympathetic activation — should prompt stopping and evaluating if symptoms are significant or persistent. Second, orthostatic symptoms (dizziness or lightheadedness on standing) during extended fasts reflect volume depletion and are a signal to reassess hydration and electrolyte intake before continuing. If blood pressure consistently rises above baseline during fasting with accompanying symptoms, clinical evaluation is warranted before continuing — thresholds relevant to Stage 1 and Stage 2 hypertension are covered in the companion article on dangerous high blood pressure.

When blood pressure rises during a fast instead

Most evidence points to fasting lowering blood pressure over time — but two mechanisms push in the opposite direction, and both are worth understanding before interpreting an unexpected reading.

The first is early-fast sympathetic activation. In the first 12 to 24 hours of a fast, the body elevates catecholamine levels as part of its metabolic adaptation to reduced glucose availability. As described in the physiology section above, catecholamines are vasoconstrictors: they narrow blood vessels and raise heart rate, producing a transient blood pressure rise before the sympathetic response attenuates as fat oxidation takes over as the primary fuel. This is a normal part of the metabolic transition, not a sign that fasting is harmful — but it does mean that a single blood pressure reading taken on day one of a fast may look worse than the longer-term trend.

The second mechanism is dehydration-induced compensatory hypertension. When fluid intake is insufficient during a fast, blood volume falls. The body responds by activating renin-angiotensin-aldosterone signaling and increasing sympathetic tone — both of which raise blood pressure as a compensatory response. If dehydration becomes more severe, these mechanisms are eventually overwhelmed and blood pressure drops, often presenting as orthostatic hypotension. The intermediate stage — compensatory BP elevation from mild-to-moderate dehydration — can produce readings that look like hypertension when the underlying cause is simply inadequate hydration.

If blood pressure consistently rises above baseline during fasting periods and this is accompanied by headache, palpitations, or dizziness, clinical evaluation is warranted before continuing a fasting practice.

When fasting blood pressure warrants medical input

If you are combining fasting with antihypertensive medications, or if you are experiencing dizziness, palpitations, or headaches during fasting periods — that is a conversation with your prescribing provider, not a self-managed protocol. The interaction between fasting and blood pressure medication dosing warrants medical guidance before you extend your fasting window.

Understanding the markers behind your readings is the foundation of Superpower's approach to preventive health.